Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03418129 · ClinicalTrials.gov registry record · NA
Neuromodulatory Treatments for Pain Management in TBI
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 254
- Enrollment target
NCT03418129 is a NA study that has completed, run by Duke University. The registered enrollment target is 254 participants.
The verdict
NCT03418129, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 254 participants
- Enrollment target
Study Summary
Traumatic brain injury (TBI) and chronic pain are common and serious health problems for military veterans and often co-occur, leading to poor post-deployment adjustment. Pharmacological treatments for pain elevate risk of opioid abuse, and research suggests veterans perceive barriers to existing non-pharmacological, clinic-based treatments. Thus, there is an urgent need to develop pain management approaches that are effective, overcome barriers to care, and are readily usable by Veterans. Evidence suggests that neuromodulatory treatments, grounded in understanding of neurophysiological mechanisms of pain, reduce pain-related symptoms and have the potential to be developed into self-directed treatments through use of mobile technology.
Interventions
- DEVICE Neurofeedback
- DEVICE Mindfulness
- DEVICE Relaxation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 254 participants |
| Start Date | 2018-09-05 |
| Est. Completion | 2022-08-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03418129
The ClinicalTrials.gov registry entry for NCT03418129 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 254 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Neurofeedback is the first listed.
NCT03418129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03418129 about?
NCT03418129 is a clinical study titled "Neuromodulatory Treatments for Pain Management in TBI". Traumatic brain injury (TBI) and chronic pain are common and serious health problems for military veterans and often co-occur, leading to poor post-deployment adjustment. Pharmacological treatments for pain elevate risk of opioid abuse, and research suggests veterans perceive barriers to existing no...
What is the current status of trial NCT03418129?
This trial is currently completed. It is a NA study. The enrollment target is 254 participants. The study started on 2018-09-05. Estimated completion is 2022-08-26.
What interventions are being tested in trial NCT03418129?
The interventions under investigation include: Neurofeedback (DEVICE), Mindfulness (DEVICE), Relaxation (DEVICE).
Who is sponsoring clinical trial NCT03418129?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.